A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Breast Cancer|Breast Cancer Stage IV|Triple Negative Breast Cancer|Triple Negative Breast Neoplasms|Metastatic Triple-Negative Breast Carcinoma|Locally Advanced Breast Cancer|Locally Advanced Triple-Negative Breast Carcinoma
Interventions: DRUG: Pembrolizumab|DEVICE: Cryoablation
Sponsor: Memorial Sloan Kettering Cancer Center